Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Overactive Bladder Symptoms (OAB) cured by surgery Cerrahi ile tedavi edilen aşırı aktif mesane semptomlar A. Gunnemann 13. Ulusal Jinekoloji ve Obstetrik Kongresi Belek/Antalya 12.05.2015 OLD DEFINITION OAB symptoms: - associated with the unstable bladder ( bladder contracting involuntarily during the filling phase of a cystometrogram) - detrusor hyperreflexia (if neurological disease was present) - detrusor instability (if the cause was unknown or non-neurogenic). CURRENT DEFINITION: The overactive bladder syndrome (OAB) is defined as urinary urgency, usually with urinary frequency and nocturia, with or without urgency urinary incontinence International Continence Society (ICS) Standardisation of Terminology of Lower Urinary Tract Symptoms and the joint ICS and International Urogynecological Association (IUGA) report on the Terminology for Female Pelvic Floor Dysfunction Treatment of neurogenic urgency incontinence: - Neuromodulation - percutaneous tibial nerve stimulation (PTNS) - bladder augmentation - Botulinium toxin injection 4 Treatment of non neurogenic Urgency Incontinence (ICS): antimuscarinic and anticholinergic drugs: darifenacin, fesoterodine, oxybutynin, propiverine, solifenacin, tolterodine, trospium and Beta3 agonists None of the drugs are an ideal first-line treatment for all OAB/DO patients: treatment individualisation patient’s comorbidities, concomitant medications and pharmacologic profiles of different drugs. BUT large metanalyses show clearly that the drugs provide a significant benefit Anticholinergic therapy: do the patients take the pills prescribed Jundt et al. 2011 After 12 months at least (N = 132) 38 % (N = 51) take the drug furthermore N = 23 (17 %) continent, much improved and satisfied N = 17 only few improved und unsatisfied N = 11 not improved 62 % (N = 81) withdraw the drug For different reasons, stress and urge derive mainly from laxity in the vagina or its supporting ligaments, a result of altered collagen/elastin www.integraltheory.org P. Petros, U. Ulmsten 1990 Connective tissue at the pelvic floor which can be loose and surgically be repaired (Petros) Anterior Zone (Meatus urethrae to bladder neck) pubourethral ligament hammock extraurethral ligament Middle Zone (bladder neck to anterior cervix) Arcus tendineus fasciae pelvis pubocervical fascia cervical ring Posterior Zone (posterior cervix to anal canal) uterosacral ligament rectovaginal fascia perineal body Tethered vagina: contracted vaginal scar at bladder neck Trampolinanalogy The stretch receptors “N” Transient Receptor Potential channels (TRPs) in the urothelium “TRPs” are sensitive to pressure. They release chemicals such NO (nitrous oxide) and ATP which stimulate afferent nerve fibres (NF), smooth muscle cells (SMC) and interstitial cells (ICC). From Everaerts et al 2008 STRAINING The anterior vaginal wall acts like a trampoline beneath the bladder DYNAMIC ANATOMY OF STRESS URINARY CONTINENCE the key role of the pubourethral ligament Nocturia causation- patient lying supine in bed Empty bladder-dark green enclosed by red broken lines A weak uterosacral ligament ( USL) cannot support the filling bladder which is stretched downward by gravity ‘G’. Stretch receptors “N” Send afferent impulses to cortex USL perceived as urgency which wakens the patient (nocturia). G De Boer et al. 2010 Prevalence of OAB Symptoms in Relation to Symptoms and Signs of POP In Community-Based Studies (Boer et al. 2010) Community-based studies N Frequency of OAB Symptoms in women with POP without POP RR (POP/no POP) Tegerstedt et al. 2005 5.489 22,5 % (454) 2,9 % (5.035) 5,8 Lawrence et al. 2008 4.103 36,8 % (239) 9,1 % (3.799) 4,0 228 52,0 % (223) 25,0 % (44) 2,1 34,4 % (96) 2,1 Miedel et al. 2008 Fritel et al. 2009 2.640 16,2 % (2.544) Prevalence of OAB Symptoms Before and After POP Surgery without Concomitant Incontincene Surgery (de Boer et al. 2010) Author: N Follow-up months Frequency of OAB symptoms preoperative postoperative RR (pre/post) Stanton et al. 1991 Jörgensen et al. 1987 Chaikin et al. 2000 Nguyen, Bhatia 2001 Weber et al. 2001 Sivaslioglu et al. 2005 Farnsworth 2004 Farnsworth 2004 Milani et al. 2005 Salvatore et al. 2005 Brubaker et al. 2006 Digesu et al. 2007 Natale et al. 2007 Basu et al. 2009 Li Marzi et al. 2006 Miedel et al. 2008 Natale et al. 2008 Siviasloglu et al. 2009 44 16 10 38 82 30 59 24 32 64 165 93 27 49 51 111 272 85 24 37 47 27,3 % 87,5 % 40 % 100 % 53,3 % 53,3 % 41 % 62,5 % 50 % 75,3 % 28,1 % 62,3 % 44,4 % 100 % 37,2 % 27,9 % 46,7 % 24,7 % 23 16 18,4 19,4 17 93 3 12 9 2,5 17,7 12 60 12 4,2 % 63 % 20 % 36,8 % 13,3 % 13,3 % 15,5 % 21,7 % 40 % 16,3 % 11,9 % 17,2 % 14,8 % 46,7 % 5,8 % 18 % 22,1 % 2,4 % 6,5 1,4 2,0 2,7 7,0 4,0 2,6 2,9 1,3 4,6 2,4 3,7 3,0 2,1 6,4 1,6 2,1 10,3 Petros 2009 Tissue Fixation System Symptomatic Results (n=71) - Time 9 months Stress incontinence n=35 (87%) Faecal incontinence n= 23 (87%) Abnormal emptying n=53 (73%) Urge incontinence (>2/D) n=36 Nocturia (>2/N) N=47 Pelvic pain n=46 (78%) (83%) (86%) Uterovaginal Prolapse (97%) (n=67) Petros 2004 Surgical treatment of mixed and urge incontincen in women Jäger W et al. 2012 (prolapse stage 4: N = 0 stage 3: N = 2: stage 2: N = 2, stage1: N 129) Elevate anterior/apikal N = 142 Fixation by minianchor with less tissu trauma Monofil, makroporous, lightweight (24,2 g/m2) Mesh (Intelpro lite, AMS) Elevate anterior/apikal – Symptomscores preop. and after 24 months. Variable PISQ Baseline (N) 32 (N=59) Follow-up (N) 36 (N=56) p-Value < 0,001 UIQ 27 (N=142) 4,7 (N=124) < 0,001 CRAIQ 12,4 (N=135) 2,6 (N=124) < 0,001 POPIQ 19,8 (N=141) 1,8 (N=124) < 0,001 PFIQ 58,6 (N=139) 9,1 (N=124) < 0,001 UDI (obstr./discomfort) 35,2 (N=14) 6,5 (N=124) < 0,001 UDI (irritative) 27,7 (N=142) 8,1 (N=124) < 0,001 UDI (stress) 23,9 (N=142) 5,8 (N=124) < 0,001 POPDI (general) 43,3 (N=142) CRADI (obstructive) 29,8 (N=142) CRADI (Incontinence) 21,8 (N=142) CRADI (Pain/Irritation) 5,8 (N=124) 9,6 (N=124) 9,1 (N=124) 21,0 (N=142) < 0,001 < 0,001 < 0,001 7,5 (N=124) < 0,001 Elevate posterior/apikal – Symptomscores preop. and after 24 months Variable Präop. (N) Follow-up (N) p-Value PISQ 33 (N=57) 36 (N=49) < 0,001 UIQ 28 (N=137) 8,5 (N=112) < 0,001 CRAIQ 18,3 (N=135) 5,6 (N=112) < 0,001 POPIQ 19,4 (N=136) 4,6 (N=112) < 0,001 PFIQ 65,4 (N=135) 18,8 (N=112) < 0,001 UDI 98,5 (N=139) 29,4 (N=113) < 0,001 POPDI 123,8 (N=139) 37,6 (N=113) < 0,001 CRADI 111,2 (N=139) 42,7 (N=112) < 0,001 PFDI-question 18 Do you usually feel a strong urge to void your bladder ? 35,2 % P < 0,01 70,0 % P < 0,01 70,0 % P < 0,01 71,3 % Nocturia cure rates after reconstruction of apical descent Author Patients with Nocturia Follow-up N Patients cured N % Petros 2008 9-21 m 47 39 83 % < 0,01 Inoue 2012 3-57 m 88 61 69 % < 0,01 Sivasioglu 2011 10-22 m 38 23 61 % < 0,05 42 34 81 % < 0,01 Farnsworth 2003 12 m p Pessary treatment for pelvic organ prolapse and health-related quality of life: a review Lamers BHC, Broekman BMW, Milani AL. Int Urogynecol J 2011;22:637-644 Cystocele Folie - 26 - simulated operation by inserting a tampon (temporary pessary) Folie - 27 - Summary • Urge incontinence can be caused by pelvic organ prolapse • Surgery can cure female urge incontinence in up to 80 % by careful anatomical pelvic floor reconstruction • Special case: „Tethered vagina Syndrom“ PFDI Question 17: „do you urinate usually very often ?“ 31,6 % P < 0,01 71,7 % P < 0,01 72,0 % P < 0,01 72,7 % PFDI question 19 Do you loose urine while have a strong feeling of urgency? 42,7 % P < 0,01 74,1 % P < 0,01 75,7 % P < 0,01 75,6 % PFDI question 27 Does urgency wake you up during the night? 31,0 % P < 0,01 58,3 % P < 0,01 57,4 % P < 0,01 55,8 %